Cargando…

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action

The highly conserved RAS-mitogen activated protein kinase (MAPK) signaling pathway is involved in a wide range of cellular processes including differentiation, proliferation, and survival. Somatic mutations in genes encoding RAS-MAPK components frequently occur in many tumors, making the RAS-MAPK a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masliah-Planchon, Julien, Garinet, Simon, Pasmant, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122439/ https://www.ncbi.nlm.nih.gov/pubmed/26646588 http://dx.doi.org/10.18632/oncotarget.6476

Ejemplares similares

RAS MAPK inhibitors deregulation in leukemia
por: Pasmant, Eric, et al.
Publicado: (2015)

Deciphering miRNAs’ Action through miRNA Editing
por: Correia de Sousa, Marta, et al.
Publicado: (2019)

The role of epigenetics and miRNAs in neuroblastoma development
por: Rupani, KV, et al.
Publicado: (2012)

MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs
por: Amini, Javad, et al.
Publicado: (2023)

miRNAs trigger widespread epigenetically-activated siRNAs from transposons in Arabidopsis
por: Creasey, K.M., et al.
Publicado: (2014)

Inflammasomes: Exosomal miRNAs loaded for action
por: Matikainen, Sampsa, et al.
Publicado: (2020)

Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription
por: Hulf, Toby, et al.
Publicado: (2011)

Modulation of Bacterial sRNAs Activity by Epigenetic Modifications: Inputs from the Eukaryotic miRNAs
por: Felden, Brice, et al.
Publicado: (2018)

Inhibition of the JNK/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development
por: Xie, Shu-Juan, et al.
Publicado: (2018)

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
por: Bosutti, Alessandra, et al.
Publicado: (2016)

Circulating miRNAs as Epigenetic Mediators of Periodontitis and Preeclampsia Association
por: Zhang, Wangmeng, et al.
Publicado: (2022)

A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
por: Hasan, Hera, et al.
Publicado: (2023)

Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
por: Tomasetti, Marco, et al.
Publicado: (2019)

Modes of action and diagnostic value of miRNAs in sepsis
por: Antonakos, Nikolaos, et al.
Publicado: (2022)

Mechanisms of Action of MiRNAs and LncRNAs in Extracellular Vesicle in Atherosclerosis
por: Xu, Hui, et al.
Publicado: (2021)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia
por: Huang, Xiaomeng, et al.
Publicado: (2016)

Dystrophin Orchestrates the Epigenetic Profile of Muscle Cells Via miRNAs
por: Marrone, April K., et al.
Publicado: (2011)

About miRNAs, miRNA seeds, target genes and target pathways
por: Kehl, Tim, et al.
Publicado: (2017)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
por: Gillies, Taryn E, et al.
Publicado: (2020)

Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs
por: Wang, Man, et al.
Publicado: (2019)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
por: Kumar, Vivek, et al.
Publicado: (2021)

Circulating miRNAs as new activators of the JAK-STAT3 pathway
por: Lam, David, et al.
Publicado: (2013)

Regulation and mechanism of action of miRNAs on insulin resistance in skeletal muscles
por: Beilerli, Aferin, et al.
Publicado: (2023)

Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes
por: Kent, Oliver A., et al.
Publicado: (2020)

miRNAs and cancer
por: Wiemer, Erik A C
Publicado: (2006)

Adenovirus and miRNAs()
por: Carnero, Elena, et al.
Publicado: (2011)

Glioblastoma and MiRNAs
por: Ahmed, Swalih P., et al.
Publicado: (2021)

Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway
por: Tsai, Hong-Chieh, et al.
Publicado: (2021)

Harmine suppresses hyper-activated Ras–MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans
por: Ji, Jiaojiao, et al.
Publicado: (2019)

Therapeutics targeting angiogenesis: Genetics and epigenetics, extracellular miRNAs and signaling networks (Review)
por: KATOH, MASARU
Publicado: (2013)

The Ras/MAPK Pathway Is Required for Generation of iNKT Cells
por: Hu, Taishan, et al.
Publicado: (2011)

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
por: Katoh, Masaru
Publicado: (2014)

MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2020)

miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy
por: Pottoo, Faheem Hyder, et al.
Publicado: (2021)

A cell-based probabilistic approach unveils the concerted action of miRNAs
por: Mahlab-Aviv, Shelly, et al.
Publicado: (2019)

MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
por: Masliah-Planchon, Julien, et al.
Publicado: (2013)

MiRNAs and miRNA Polymorphisms Modify Drug Response
por: Li, Mu-Peng, et al.
Publicado: (2016)

KSR induces RAS‐independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors
por: Paniagua, Guillem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ggmmtatmhhub8v778mkdpkn9tj